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ABSTRACT
Background: Health related quality of life (HRQOL) is increasingly being recognised 
as a primary outcome measure in the treatment of end stage renal disease. In addition 
to being an important surrogate marker of quality of care in patients on maintenance 
haemodialysis, HRQOL measures have being shown to be robust predictors of mortality 
and morbidity.  
Objective: To determine the health related quality of life and its determinants in 
patients on maintenance haemodialysis at the Kenyatta National Hospital.
Design: A cross-sectional descriptive study.
Setting: Renal unit, Kenyatta National Hospital
Subjects: Adult patients with end stage renal disease on maintenance haemodialysis.  
Results: The mean physical composite summary and mental composite summary 
scores were 39.09±9.49 and 41.87±10.56 respectively. The burden of kidney disease 
sub-scale, symptom and problems sub-scale and effect of kidney disease on daily 
life sub-scale scores were 16.15±21.83, 73.46±18.06 and 67.63±23.45 respectively. No 
significant correlations were found between the health-related quality of life scores, 
socio-demographic and clinical factors assessed.
Conclusion: The health-related quality of life of patients on maintenance haemodialysis 
is reduced. The physical quality of life is more affected than the mental quality of 
life. No independent determinants of health-related quality of life were identified.  
INTRODUCTION
Patients with End Stage Renal Disease (ESRD) on 
maintenance Haemodialysis (HD) have significantly 
lower health related quality of life (HRQOL) than age 
matched general population, with physical health 
particularly more affected than the mental health 
(1-6). Within the physical composite score (PCS) the 
health domain most affected is the role-functioning 
physical which limits ability to participate in normal 
daily roles and activities (1). Patients on haemodialysis 
have lower scores than renal transplant patients in 
multiple studies (3, 7).
 Over the last decade, multiple advances have 
been made in treatment of anaemia, adequacy of 
dialysis and use of erythropoietin and Vitamin D 
in patients on haemodialysis. However, this has not 
translated to an improvement of HRQOL. 
 Several factors are associated with HRQOL 
outcomes in patients on maintenance haemodialysis. 
Gender is a powerful predictor of HRQOL scores in 
multiple studies, with females manifesting lower 
scores in multiple domains especially physical health 
(1, 8, 9).
 Increasing age has been shown to correlate 
negatively with quality of life (9). Older patients 
have lower physical health scores whereas younger 
patients have lower mental health scores (10).
 High socio-economic status as evidenced by 
increased income and level of education correlates 
positively with quality of life (11).
 Anaemia is associated with reduced quality of 
life, and haemoglobin levels predict both physical 
and mental domains on the SF-36 (4, 8, 9, 12).
 Nutritional biomarkers have moderate to large 
predictive power of HRQOL. These include Serum 
albumin, Creatinine and Body mass index (BMI) (13). 
Low creatinine levels and low body mass index are 
significantly associated with lower quality of life 
scores (13).
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Co-morbidities, particularly cardio-vascular diseases 
and risk factors are associated with lower HRQOL 
scores (4, 14, 15).   Diabetic patients on dialysis have 
lower self-rated physical health compared to non-
diabetics on dialysis (15). Patients with hypertension, 
especially if poorly controlled, have lower quality of 
life than patients with normal blood pressure (16).
 Although adequacy of dialysis is a strong 
predictor of survival, its relationship with HRQOL 
is inconsistent (6, 13).  
 Patients with ESRD on dialysis bear a heavy 
symptom burden of fatigue, cognitive difficulty, sleep 
disturbance, sexual dysfunction, pain and depression 
which negatively affect HRQOL (17, 19, 20).  
 HRQOL scores serve as a useful and relatively 
convenient screening instrument for the risk of death 
and hospitalisation. Assessment of HRQOL may 
identify patients with undiagnosed or inappropriately 
treated depression who may benefit from standard 
interventions. An MCS score of less than 42 is highly 
sensitive and specific for depression (9).
 Several interventions improve HRQOL scores 
among patients with ESRD on haemodialysis. These 
include treatment of anaemia, management of pain 
and sleep disturbances, exercise programmes, renal 
transplantation, improved bone mineral metabolism, 
treatment of restless leg syndrome with Gabapentin, 
and treatment of sexual dysfunction. Short daily and 
long nocturnal haemodialysis improves HRQOL 
scores. In addition, counselling in response to 
individual patient’s issues and cognitive behavioural 
therapy can be helpful (21).
MATERIALS AND METHODS
The study was conducted at the Kenyatta National 
Hospital renal unit after obtaining ethical approval 
from the ethical and research committee. Patients 
with ESRD aged 18 years and above on maintenance 
haemodialysis were considered eligible. Patients 
who had been on dialysis for less than three months, 
patients hospitalised in the last four weeks and 
patients with cognitive impairment, psychosis and 
dementia, were excluded from the study. 
 Demographic and socio-economic history was 
obtained through direct questioning of the patient and 
recorded in the study proforma. Primary diagnosis, 
co-morbidities and treatment history were derived 
from patients’ medical record. Physical examination 
was carried out and co-morbidities and their 
associated complications noted. Height and weight 
were measured for each patient and body mass index 
calculated. Adequacy of dialysis was calculated using 
Kt/v. 
Laboratory methods: Albumin was analysed using the 
Technicon RA-1000 machine. Haematocrit levels were 
analyzed using the microhaematocrit centrifuge. The 
readings were done using a microhematocrit reader. 
For patients who had albumin and haematocrit levels 
measured over the last three months, an average of 
the results was recorded.
 HRQOL was measured by the KDQOL-36 
questionnaire. The KDQOL-36 questionnaire is a 
validated instrument, used in multiple studies and 
recommended by the National Kidney Foundation 
(22, 23).  
 The first 12 items of the KDQOL-36 are the 
Medical Outcomes Survey (MOS) SF-12 survey, 
which measures patients’ perceptions of their own 
physical and mental functioning. In addition, there 
are 24 kidney-disease specific questions. The five 
scores derived from the KDQOL-36 are: 
1. Physical component summary (PCS) (items 
1-12)—an overall measure of physical functioning 
that assesses physical limitations, energy level 
and general health. 
2. Mental component summary (MCS) (items 
1-12)—an overall measure of mental functioning 
that assesses tasks, depression, anxiety and social 
activities. 
3. Burden of kidney disease sub-scale (items 13-
16)—how much kidney disease interferes with 
daily life, takes up time, causes frustration, or 
makes the respondent feel like a burden. 
4. Symptoms and problems sub-scale (items 17-
28b)—how bothered a respondent feels by sore 
muscles, chest pain, cramps, itchy or dry skin, 
shortness of breath, faintness/dizziness, lack 
of appetite, feeling washed out or drained, 
numbness in the hands or feet, nausea, or 
problems with dialysis access. 
5. Effects of kidney disease on daily life sub-scale 
(items 29-36)—how bothered the respondent feels 
by fluid limits, diet restrictions, ability to work 
around the house or travel, feeling dependent on 
doctors and other medical staff, stress or worries, 
sex life, and personal appearance. 
The questionnaire was in english language and was 
interviewer administered.  For patients who did 
not understand English the principal investigator 
translated the questions to a language they best 
understood or used a translator. A mark was put 
against the patient’s response. Those questions that 
the patient did not answer were left blank.
Data analysis: The data collected were entered into 
EXCEL and password protected.
Survey scoring: An Excel scoring spreadsheet with 
an example and instructions was obtained from the 
UCLA website at www.gim.med.ucla.edu/kdqol.
 Each question had a maximum of 100 points with 
a higher scores indicating better health. The scales had 
a maximum of 100 points with higher scores indicating 
better health. Scale scores were computed if at least 
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one item in the scale was answered. The scores were 
computed as the average of the answered items.
 Continuous variables were summarised into 
means and standard deviations. Categorical data were 
summarised into proportions. Relationships between 
HRQOL Scores and the continuous variables were 
analyzed by Pearson correlation or Spearman rank 
correlation. Relationships between HRQOL scores 
and categorical variables were analysed using the 
student T test /ANOVA. Significant level was set at 
a P<0.05. 
RESULTS
A total of 130 out of the 144 patients on maintenance 
haemodialysis were screened. Ninety six patients 
(66.7%) met the inclusion criteria and were included 
in the study. The baseline characteristics of the study 
participants. Table 1. 
Table 1
Baseline characteristics of the study participants
Characteristic Population
Male: female ratio 1.91:1
Age, mean (SD) yrs. 44 (±13.98)
Employment status (%)
       Employed 25
       Retired 27.1
       Unemployed 47.9
Education level (%)
       Uneducated 0
       Primary 21.9
       Secondary 45
       Tertiary 31.3
Duration of dialysis (range) months 3-156
Primary renal disease (%)
        Hypertension 53.1
        Diabetes mellitus 30.2
        Chronic glomerulonephritis 7
        Polycystic kidney disease 3.1
        Bladder outlet obstruction 5.26
Co-morbidity (%) 
         None 0
         Hypertension 26
         Hepatitis B 4.2
         Osteoarthritis 2
         Hypertensive heart disease 2
         Diabetes mellitus 2
         BPH 2.1
         HIV 1
         Hypothyroidism 1
        PUD 3
Body Mass Index,  mean (SD) kg/m2 22.75(±3.94)
Adequacy of Dialysis, mean (SD) kt/v 2.05(±0.43)
Haematocrit level, mean (SD) 26.35(±7.17)
Albumin levels, mean (SD) g/l 38.56(±9.32)
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HRQOL: The mean physical composite summary and 
mental composite summary scores were 39.09±9.49 
and 41.87±10.56 respectively. The population norms 
for the PCS and MCS scores are 50±10.
 The burden of kidney disease sub-scale, 
symptom and problems sub-scale and effect of kidney 
disease on daily life sub-scale scores were 16.15±21.83, 
73.46±18.061 and 67.63±23.45 respectively. The sub-
scale scores range from 0-100 with higher scores 
indicating better health. Pearson’s and Spearman’s 
rank correlation between clinical indicators and PCS 
& MCS scores. Table 2.
Table 2




*DURATION OF DIALYSIS 0.049 0.017
p-value 0.638 0.869
COMORBIDITY NO. -0.184 -0.127
p-value 0.073 0.221








*spearman’s rank correlation was done for dialysis duration
Student T Test and Analysis of Variance (ANOVA) were conducted for categorical variables as shown in 
the Table 3.
Table 3












P value 0.512 0.212
DM 37.32 39.92
NON-DM 39.86 42.72
P value 0.231 0.235
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There were no significant associations between the 
composite scores and socio-demographic and clinical 
variables.
 Sub-scale scores were not significantly associated 
with socio-demographic and clinical variables.
DISCUSSION 
The socio-demographic and clinical characteristics 
found in this study were similar to those of similar 
populations in previous studies done at the KNH 
renal unit.  
 In this study, the mean PCS Score was 39.09 
±9.49 and the mean MCS Score was 41.87±10.57. This 
finding is consistent with multiple studies that have 
found the HRQOL of life of patients on maintenance 
haemodialysis to be reduced (5, 8, 21, 24, 25, 26).
 The symptoms and problem sub-scale score was 
73.46 ±18.06. The effect of kidney disease on daily life 
sub-scale score was 67.63±23.45. The burden of kidney 
disease sub-scale score was16.15±21.83. A similar 
trend of very low scores in the burden of kidney 
disease sub-scale and relatively good scores in the 
effect of kidney disease on daily life sub-scale and 
symptoms and problem sub-scale have been noted 
in studies conducted in centres offering conventional 
three times a week dialysis (27).
 Though multiple studies have shown significant 
correlation between age, gender, duration of dialysis, 
employment status and education level, this 
study failed to identify any statistically significant 
correlation between socio-demographic factors and 
HRQOL scores (2, 4, 10, 14, 21). 
 Yamana et al (studied 44 Japanese patients) and 
Bokhle et al (among 140 South Brazilian patients) 
found no correlation between age, gender, social-
economic status and the HRQOL scores which they 
attributed to small sample sizes and homogenous 
results (24,27).   
 Though no significant associations were noted 
between the HRQOL and the socio-demographic 
factors assessed, some trends were identified.   
 Females had lower scores than males, even 
though females were significantly younger than their 
male counterparts; yet increasing age has been shown 
to negatively affect HRQOL (2, 8, 9, 11). Multiple 
studies that have shown females to have lower scores 
(2, 8, 9, 11). The exact cause for lower HRQOL in 
females with ESRD is not clear, but women tend to 
be more apprehensive about their bodily image and 
appearance which are impacted negatively by dialysis 
through fluid overload and insertion of vascular 
access (11).   Additionally, as women in Kenya are less 
socio-economically empowered than men, they may 
feel more burden some to their families (11). Women 
have numerous domestic tasks and responsibilities 
that they may not be able to circumvent despite illness 
and which impact negatively on their quality of life 
(9).
 The MCS score in this study was 42.19 in 
patients less than 44 years old and 41.59 in patients 
aged 44 or older (p=0.784). Other studies have found 
older patients to have higher MCS indicating better 
emotional coping with chronic diseases (6, 9). The 
elderly patients in the present study were likely to 
have more emotional problems owing to the huge 
financial implications of dialysis particularly as most 
are unemployed. In contrast, in developed countries 
where renal replacement therapy is provided for by 
the state, the elderly cope better with dialysis. 
 Though socio-economic status as assessed by 
education level and employment status did not 
significantly correlate with the HRQOL scores, the 
PCS scores tended to be higher among those in 
employment (p=0.079). The MCS was found to be 
lower in those in employment (p=0.78).  Increased 
socio-economic status has been shown to correlate 
positively with quality of life (4, 8, 9, 11). Those in 
employment scored better in the PCS as they were 
likely to be more physically fit to sustain employment. 
Having a job is an important predictor of better mental 
quality of life. Holding a job certainly has a positive 
influence on the perception that an individual has 
on his or her role in society and contributes towards 
improved self-esteem. In this study, though not 
statistically significant, those in employment scored 
lower. This could relate to the inconvenient dialysis 
schedule and colossal amount of time spent dealing 
with their diseases both of which constantly puts 
them at risk of being declared redundant at their 
workplaces.
 None of the clinical variables assessed in this 
study correlated significantly with the HRQOL scores. 
Though numerous studies have shown hematocrit 
and albumin to be important predictors of HRQOL, 
this study did not identify any significant association 
possibly because albumin and hematocrit levels were 
relatively homogenous with results distributed within 
a narrow range (4, 8, 9,11).   The study may also have 
been under-powered to detect such an association. 
Studies showing similar results include Yamana et al 
in a study done among 44 Japanese haemodialysis 
patients, Bohlke et al among 140 Brazilian patients and 
Mingardi et al among 304 Italian   patients (24, 27, 28). 
Mingardi et al attributed their lack of correlation to 
the limited variability of the hematocrit values due 
to routine use of erythropoietin (28).
 Although adequacy of dialysis is a strong 
predictor of survival, studies on its relationship with 
HRQOL have had inconsistent outcomes. Merkus et 
al and Mingardi et al failed to identify an association 
between Kt/v and HRQOL (14, 28). Cleary and De 
Oreo did not find an association between Kt/v and 
physical functioning, but found a small statistically 
significant association between MCS and kt/v (9, 
29).  In this study though not statistically significant, 
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the HRQOL scores were consistently higher in the 
patients with adequate dialysis. This underscores 
the importance of interventions aimed at improving 
adequacy of dialysis in our patients. 
 Though dialysis duration, co-morbidity and 
primary renal disease have been shown to correlate 
with HRQOL of haemodialysis patients, this study 
did not identify a significant correlation (6, 25, 30). 
However a trend was noted in this study where DM 
was associated with reduced scores in all sub-scales. 
This is in keeping with numerous studies that have 
shown DM to be associated with reduced quality 
of life especially physical functioning (8, 14).   The 
reduced quality of life in diabetic dialysis patients is 
probably related to higher co-morbidity burden (30). 
 The failure of this study to identify any significant 
association between all variables assessed and the 
HRQOL scores could be as a result of the short dialysis 
duration and probably the impact of dialysis on QOL 
takes a longer time to be detected.
 Other factors not assessed such as role of 
social support and spirituality may be important 
determinants of quality of life in our population. 
Plantinga et al found greater life satisfaction at one 
year on dialysis among patients with higher overall 
social support compared to those with lower support 
(Odds ratio 2.47 ) (31).  HD patients who are more 
religious have also been shown to have higher quality 
of life than those who are less religious (32). 
 This study has important implications as our 
patients had markedly reduced HRQOL.  However 
modifiable interventions shown to improve HRQOL 
of HD patients such as anaemia, albumin and 
adequacy of dialysis were found not to be independent 
determinants. For instance, this means that in our 
study population correction of anaemia would not 
necessarily result in an improvement of HRQOL. 
 As such efforts to improve HRQOL in our setting 
should extend beyond strictly nephrological care. 
Other factors that could influence HRQOL such as 
social and family support, individual psychological 
factors and physical, psychological and occupational 
rehabilitation need to be evaluated in more details in 
our setting.
CONCLUSION
The HRQOL of haemodialysis patients at the KNH 
renal unit is reduced with the physical health more 
affected than the mental aspect. Among the sub-
scales, the burden of kidney disease sub-scale is the 
most affected.
 Age, gender, socio-economic status, primary 
renal disease, co-morbidities, albumin, haematocrit, 
body mass index and adequacy of dialysis did not 
correlate significantly with HRQOL. 
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